English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background: Childhood cancer is a leading cause of death. Acute myeloblastic leukemia, the second leading cause of childhood leukemia, is not uncommon in Cameroon. Methods: We conducted a descriptive retrospective study in the department of Hematology Oncology in the Mother and Child Center of Chantal Biya Foundation, from March 2011 to February 2017 that is a period of 6 years. Results: We had 25 cases; the average age was 8 years with a sex ratio of 0.92. The FAB classification found 9 cases of AML 1 (36%), 6 cases of AML 5 (24%), 3 cases of AML 3 (12%), 3 cases of AML 2 (12%), 2 cases of AML 4 (8%) and 2 (8%) cases unidentified. We treated 20 patients, 9 (45%) had complete remission. The remission period was between 1 and 48 months, for an average of 20 months. The probability of survival for patients at 50 weeks was almost nil. Mean survival was 34 weeks with a confidence interval (CI) between [10,157-58,718]. Conclusion: The treatment is possible, but the absence of management constitutes a reason for abandonment of the treatment which makes the protocols not evaluable.

Management of Acute Myeloblastic Leukemias: The Experience of the Mother and Child Center of Chantal Biya Foundation, Yaounde